Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Julphar
McKesson
UBS
Fuji
Farmers Insurance
QuintilesIMS
Accenture
US Army

Generated: April 19, 2018

DrugPatentWatch Database Preview

DAUNOXOME Drug Profile

« Back to Dashboard

When do Daunoxome patents expire, and what generic alternatives are available?

Daunoxome is a drug marketed by Galen (uk) and is included in one NDA.

The generic ingredient in DAUNOXOME is daunorubicin citrate. There are eleven drug master file entries for this compound. Additional details are available on the daunorubicin citrate profile page.
Drug patent expirations by year for DAUNOXOME
Synonyms for DAUNOXOME
(+)-Daunomycin
(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside
(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-4-methoxy-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione
(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro--6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
(8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
(8S,10S)-8-acetyl-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
11006-54-5
11048-29-6
1407-15-4
149541-57-1
15159-EP2270008A1
15159-EP2272827A1
15159-EP2277565A2
15159-EP2277566A2
15159-EP2277567A1
15159-EP2277568A2
15159-EP2277569A2
15159-EP2277570A2
15159-EP2289892A1
15159-EP2292280A1
15159-EP2292617A1
15159-EP2295416A2
15159-EP2295426A1
15159-EP2295427A1
15159-EP2298748A2
15159-EP2298778A1
15159-EP2301928A1
15159-EP2305642A2
15159-EP2305679A1
15159-EP2308833A2
15159-EP2308861A1
15159-EP2311808A1
15159-EP2311829A1
15159-EP2311842A2
15159-EP2316832A1
15159-EP2316833A1
16803-EP2272832A1
16803-EP2277565A2
16803-EP2277566A2
16803-EP2277567A1
16803-EP2277568A2
16803-EP2277569A2
16803-EP2277570A2
16803-EP2280012A2
16803-EP2281815A1
16803-EP2286812A1
16803-EP2292280A1
16803-EP2292615A1
16803-EP2298768A1
16803-EP2301928A1
16803-EP2301933A1
16803-EP2305640A2
16803-EP2305671A1
16803-EP2311825A1
16803-EP2311827A1
16803-EP2311840A1
16803-EP2316937A1
182250-71-1
20830-81-3
23942-76-9
27576-81-4
28020-80-6
30D813
5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-
5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-
5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8 ,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-
AB00514669
AB00514669-09
AB01644616_09
AB01644616_10
AC1L1JCP
AC1Q29OI
Acetyladriamycin
AI3-52942
AKOS027256614
AN-9539
Anthracycline
Anthracyline
Antibiotic F.I. 1762
Antibiotics from Streptomyces coeruleorubidus
API0005415
AX8123492
BDBM32017
BDBM50368352
BPBio1_000389
BRD-K43389675-001-01-3
BRD-K43389675-003-02-7
BRN 1445583
BSPBio_000353
C01907
C27H29NO10
CAS-20830-81-3
CCG-212559
CCRIS 914
Cerubidin
Cerubidine
CHEBI:41977
CHEMBL178
cid_62770
CS-2004
D01XWG
D07776
D08UQF
D0T7QR
Daunamycin
Daunarubicinum
Dauno-Rubidomycine
Daunoblastin
Daunoblastine
Daunomycin
Daunomycin, hydrochloride
Daunomycine
Daunorrubicina
daunorubicin
Daunorubicin (INN)
Daunorubicin (liposomal)
Daunorubicin [INN:BAN]
DAUNORUBICIN HCL
Daunorubicin, Hydrochloride
Daunorubicin(Daunomycin)
Daunorubicin(RP13057)
Daunorubicina
Daunorubicine
Daunorubicinum
Daunorubicinum [INN-Latin]
DaunoXome (TN)
DB00694
DRG-0155
DSSTox_CID_2883
DSSTox_GSID_22883
DSSTox_RID_76773
DTXSID7022883
EINECS 244-069-7
FI 6339
FI-6339
FI6339
FT-0624457
GR-318
GTPL7063
HMS2089H04
HMS2091K06
HSDB 5095
HY-13062A
Leukaemomycin C
LMPK13050002
LS-187381
LS-997
MFCD00866340
MLS000069508
MolPort-002-533-961
NCGC00024246-05
NCGC00024246-06
NCGC00024246-07
NCGC00024246-09
NCGC00024246-10
NCGC00024246-15
NCGC00025173-01
NCI-C04693
NDC 0082-4155
NDC-0082-4155
NSC 83142
NSC-756717
NSC-82151
NSC756717
NSC82151
Ondena
Pharmakon1600-01500223
PL041368
PL050176
Prestwick3_000487
RCRA waste no. U059
RP 13057
RP 13057 hydrochloride
RP-13057
Rubidomycin
Rubomycin
Rubomycin C
SBI-0206677.P002
SC-18793
SCHEMBL3041
SMR000058559
STQGQHZAVUOBTE-VGBVRHCVSA-N
Tocris-1467
Tox21_110896
Tox21_110896_1
UNII-ZS7284E0ZP
VS-103
ZINC3917708
ZS7284E0ZP

US Patents and Regulatory Information for DAUNOXOME

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galen (uk) DAUNOXOME daunorubicin citrate INJECTABLE, LIPOSOMAL;INJECTION 050704-002 Apr 8, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
UBS
McKesson
Fish and Richardson
Harvard Business School
Teva
Federal Trade Commission
Dow
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.